Papapolitis & Papapolitis advised Ambrosia Capital as Lead Underwriter in relation to the €58m pre-emptive share capital increase of Lavipharm S.A., a leading pharmaceutical company with global presence, and to the public offer in Greece of newly issued shares listed on Athex. P&P advised the Lead Underwriter on all aspects of the transaction including customary

MENU
CAREERS
SERVICES OVERVIEW